Effect of halofuginone lactate on the occurrence of Cryptosporidium parvum and growth of neonatal dairy calves

Journal of Dairy Science

Volumn 88, Issue 5, 2005, Pages 1801-1806

  Jarvie, B D ^a   Trotz Williams, L A ^a   McKnight, D R ^b   Leslie, K E ^a   Wallace, M M ^a   Todd, C G ^b   Sharpe, P H ^b   Peregrine, A S ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Cryptosporidiosis; Diarrhea; Halofuginone lactate; Neonatal calf

Indexed keywords

CRYPTOSPORIDIUM PARVUM;

COCCIDIOSTATIC AGENT; HALOFUGINONE LACTATE; PLACEBO; QUINAZOLINE DERIVATIVE; QUINAZOLINONE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; FECES; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MALE; NEWBORN; PARASITOLOGY; RANDOMIZED CONTROLLED TRIAL; WEANING; WEIGHT GAIN;

ANIMALS; ANIMALS, NEWBORN; CATTLE; CATTLE DISEASES; COCCIDIOSTATS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; FECES; MALE; PLACEBOS; QUINAZOLINES; QUINAZOLINONES; WEANING; WEIGHT GAIN;

EID: 20844448904     PISSN: 00220302     EISSN: None     Source Type: Journal    
DOI: 10.3168/jds.S0022-0302(05)72854-X     Document Type: Article

References (16)

1. Anderson, B.C. 1998. Cryptosporidiosis in bovine and human health. J. Dairy Sci. 81:3036-3041.
2. Canadian Council on Animal Care. 1993. Guide to the care and use of experimental animals. Vol. 1. Canadian Council of Animal Care, Ottawa, ON, Canada.
3. Committee for Veterinary Medicinal Products. 1999. European Agency for the Evaluation of Medicinal Products. EMEA/CVMP/643/99 Halocur dossier submission. EU, Brussels, Belgium.
4. Constable, P. D. 2002. The treatment of the diarrheic calf: An update. Pages 132-143 in Recent Developments and Perspectives in Bovine Medicine. Proc. XXII World Buiatrics Congr. Hanover, Germany.
5. Fayer, R., C. A. Speer, and J. P. Dubey. 1990. General biology of Cryptosporidium. Pages 2-29 in Cryptosporidiosis of Man and Animals. J. P. Dubey, C. A. Speer, R. Fayer, ed. CRC Press, Boston, MA.
6. Fayer, R., and B. L. P. Ungar. 1986. Cryptosporidium spp. and cryptosporidiosis. Microbiol. Rev. 50:458-483.
7. Larson, L. L., F. G. Owen, J. L. Albright, R. D. Appleman, R. C. Lamb, and L. D. Muller. 1977. Guidelines toward more uniformity in measuring and reporting calf experimental data. J. Dairy Sci. 60:989-991.
8. Lefay, D., M. Naciri, P. Poirier, and R. Chermette. 2001. Efficacy of halofuginone lactate in the prevention of cryptosporidiosis in suckling calves. Vet. Rec. 148:108-112.
9. Naciri, M., R. Mancassola, P. Yvore, and J. E. Peeters. 1993. The effect of halofuginone lactate on experimental Cryptosporidium parvum in calves. Vet. Parasitol. 45:199-207.
10. NAHMS. 1993. Cryptosporidium is common in dairy calves. Pages 1-2 in USDA: APHIS: VS, Fort Collins, CO.
11. O'Handley, R. M., C. Cockwill, T. A. McAllister, M. Jelinski, D. W. Morck, and M. E. Olson. 1999. Duration of naturally acquired giardiosis and cryptosporidiosis in dairy calves and their association with diarrhea. JAVMA 214:391-396.
12. Olson, M. E., C. L. Thorlakson, L. Deselliers, D. W. Morck, and T. A. McAllister. 1997. Giardia and Cryptosporidium in Canadian farm animals. Vet. Parasitol. 68:375-381.
13. Perryman, L. E., S. J. Kapil, M. L. Jones, and E. L. Hunt. 1999. Protection of calves against Cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein. Vaccine 17:2142-2149.
14. SAS Institute. 1999-2001. SAS User's Guide: Statistics, Version 8.20 ed. SAS Inst., Inc., Cary, NC.
15. Uga, S., J. Matsua, E. Kono, K. Kimura, M. Inoue, S. K. Rai, and K. Ono. 2000. Prevalence of Cryptosporidium parvum infection and pattern of oocyst shedding in calves in Japan. Vet. Parasitol. 94:27-32.
16. Yvoré, P., and M. Naciri. 1989. Halofuginone lactate in the treatment of cryptosporidiosis in ruminant. Coccidia and Intestinal Coccidiomorphs. Vth Int. Coccidiosis Conf., Tours, France. Les Colloques de l'NRA 49:475-478.